Related Experiment Video
Updated: Jun 13, 2026
08:52
Adipo-Clear: A Tissue Clearing Method for Three-Dimensional Imaging of Adipose Tissue
Published on: July 28, 2018
Resolution of adipose tissue inflammation.
Ana González-Périz1, Joan Clària
1Department of Biochemistry and Molecular Genetics, Hospital Clinic, IDIBAPS, CIBEK, CIBERehd, University of Barcelona. agonzal2@clinic.ub.es
Thescientificworldjournal
|May 11, 2010
Summary
Obesity causes chronic inflammation in fat tissue, driven by lipid mediators. Specialized lipid mediators, like lipoxins and resolvins, can resolve this inflammation and prevent obesity-related diseases.
Area of Science:
- Biochemistry
- Immunology
- Metabolic Diseases
Background:
- Obesity is linked to chronic low-grade inflammation in adipose tissue.
- This inflammation involves macrophages and adipocytes, promoting insulin resistance and fatty liver disease.
- Bioactive lipid mediators from arachidonic acid metabolism (eicosanoids) exacerbate adipose tissue inflammation.
Purpose of the Study:
- To review the role of anti-inflammatory and proresolving lipid mediators in adipose tissue inflammation.
- To discuss omega-6 and omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediators.
- To highlight their potential in preventing obesity-related complications.
Main Methods:
- Literature review of bioactive lipid mediators.
- Focus on cyclooxygenase and 5-lipoxygenase pathways.
- Analysis of lipid mediators' roles in adipose tissue inflammation resolution.
Main Results:
- Proinflammatory eicosanoids (prostaglandins, leukotrienes) from omega-6 PUFAs contribute to obesity inflammation.
- Anti-inflammatory and proresolving lipid mediators (lipoxins, resolvins, protectins, D-series cyclopentenone PGs) can terminate inflammation.
- These "stop signals" are crucial for resolving adipose tissue inflammation.
Conclusions:
- Bioactive lipid autacoids are key regulators of adipose tissue inflammation.
- Targeting these lipid mediators offers a strategy to combat obesity-related comorbidities.
- Further research into these "stop signals" is vital for therapeutic development.
Related Concept Videos
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:38Inflammation
Overview
01:26Acute Inflammation II: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...